Prospective observational cohort study

OTHER4 trials

Sponsors

GlaxoSmithKline

Conditions

Pulmonary Disease, Chronic Obstructive

Unknown Phase

Etiology of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD) in Japan

CompletedNCT03957577

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2019-06-13End: 2022-06-30Updated: 2024-02-22

Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) Participants

CompletedNCT04657211

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2021-01-14End: 2024-07-01Updated: 2025-08-17

Chronic Obstructive Pulmonary Disease (COPD) Maintenance Treatment Patterns in China

CompletedNCT04853238

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2021-04-27End: 2023-02-06Updated: 2024-12-06

Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China

CompletedNCT04853225

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2020-04-22End: 2024-06-25Updated: 2025-08-20

Related Papers

TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.

2025-12-17

Sputum Microbiome, Potentially Pathogenic Organisms, and Clinical Outcomes in Japanese Patients with COPD and Moderate Airflow Limitation: The Prospective AERIS-J Study.

2025-05-14

Baseline patient demographics for TETRIS: a prospective, noninterventional study to characterize the use of triple therapy for COPD in Germany

Therapeutic Advances in Respiratory Disease2024-01-011 citations

Use of CAPTURE to Identify Individuals Who May or May Not Require Treatment for Chronic Obstructive Pulmonary Disease.

2023-08-018 citations

Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale

ERJ Open Research2021-07-0110 citations